Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma

G. Porcile, M. Musso, F. Boccardo, R. Rosso, L. Santi

Research output: Contribution to journalArticle

Abstract

Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalTumori
Volume65
Issue number2
Publication statusPublished - 1979

Fingerprint

Dacarbazine
Vinblastine
Combination Drug Therapy
Methotrexate
Melanoma
Bleomycin
indium-bleomycin
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma. / Porcile, G.; Musso, M.; Boccardo, F.; Rosso, R.; Santi, L.

In: Tumori, Vol. 65, No. 2, 1979, p. 237-240.

Research output: Contribution to journalArticle

Porcile, G. ; Musso, M. ; Boccardo, F. ; Rosso, R. ; Santi, L. / Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma. In: Tumori. 1979 ; Vol. 65, No. 2. pp. 237-240.
@article{76044553e272468997b6bc7bcc4e7d4b,
title = "Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma",
abstract = "Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.",
author = "G. Porcile and M. Musso and F. Boccardo and R. Rosso and L. Santi",
year = "1979",
language = "English",
volume = "65",
pages = "237--240",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma

AU - Porcile, G.

AU - Musso, M.

AU - Boccardo, F.

AU - Rosso, R.

AU - Santi, L.

PY - 1979

Y1 - 1979

N2 - Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.

AB - Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.

UR - http://www.scopus.com/inward/record.url?scp=0018777426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018777426&partnerID=8YFLogxK

M3 - Article

C2 - 88784

AN - SCOPUS:0018777426

VL - 65

SP - 237

EP - 240

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -